The Pharmacokinetics of 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides: Experiences from Developing Exon Skipping Therapies for Duchenne Muscular Dystrophy
Bosgra S, Sipkens J, de Kimpe S, den Besten C, Datson N, van Deutekom J. Nucleic Acid Ther. 2019 Aug 20. PubMed
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
Witztum JL, Gaudet D, Freedman SD, Alexander VJ, Digenio A, Williams KR, Yang Q, Hughes SG, Geary RS, Arca M, Stroes ESG, Bergeron J, Soran H, Civeira F, Hemphill L, Tsimikas S, Blom DJ, O'Dea L, Bruckert E. N Engl J Med. 2019 Aug 8;381(6):531-542. ...
FLAM-seq: full-length mRNA sequencing reveals principles of poly(A) tail length control
Legnini I, Alles J, Karaiskos N, Ayoub S, Rajewsky N. Nat Methods. 2019 Sep;16(9):879-886. PubMed
Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545
Zhang X, Yang H, Zhao L, Li G, Duan Y. Cell Death Dis. 2019 Aug 13;10(8):616. PubMed
N6-Methyladenosine Modification Controls Circular RNA Immunity
Chen YG, Chen R, Ahmad S, Verma R, Kasturi SP, Amaya L, Broughton JP, Kim J, Cadena C, Pulendran B, Hur S, Chang HY. Mol Cell. 2019 Aug 7. PubMed
A blue light receptor that mediates RNA binding and translational regulation
Weber AM, Kaiser J, Ziegler T, Pilsl S, Renzl C, Sixt L, Pietruschka G, Moniot S, Kakoti A, Juraschitz M, Schrottke S, Lledo Bryant L, Steegborn C, Bittl R, Mayer G, Möglich A. Nat Chem Biol. 2019 Aug 26. PubMed
Reactive modifications of DNA nucleobases for labelling, bioconjugations, and cross-linking
Ivancová I, Leone DL, Hocek M. Curr Opin Chem Biol. 2019 Aug 12;52:136-144. PubMed
Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease
Zeitler B, Froelich S, Marlen K, Shivak DA, Yu Q, Li D, Pearl JR, Miller JC, Zhang L, Paschon DE, Hinkley SJ, Ankoudinova I, Lam S, Guschin D, Kopan L, Cherone JM, Nguyen HB, Qiao G, Ataei Y, Mendel MC, Amora R, Surosky R, ...
Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
Kanter JE, Shao B, Kramer F, Barnhart S, Shimizu-Albergine M, Vaisar T, Graham MJ, Crooke RM, Manuel CR, Haeusler RA, Mar D, Bomsztyk K, Hokanson JE, Kinney GL, Snell-Bergeon JK, Heinecke JW, Bornfeldt KE. J Clin Invest. 2019 Jul 11;130. PubMed
The nuclear concentration required for antisense oligonucleotide activity in myotonic dystrophy cells
van der Bent ML, Paulino da Silva Filho O, Willemse M, Hällbrink M, Wansink DG, Brock R. FASEB J. 2019 Jul 16 PubMed
